AI assistant
Sending…
Applied Therapeutics, Inc. — Director's Dealing 2025
Mar 27, 2025
34263_dirs_2025-03-26_685df0a5-a178-4101-a12e-ad00bcc22a4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Applied Therapeutics, Inc. (APLT)
CIK: 0001697532
Period of Report: 2025-03-24
Reporting Person: Funtleyder Leslie D. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-24 | Common Stock | A | 350000 | — | Acquired | 740459 | Direct |
Footnotes
F1: Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. One fourth (1/4th) of the compensatory RSUs shall vest on March 24, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory RSUs shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
More from Applied Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Delisting Announcement
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3